Center Laboratories, Inc. (4123.TWO)
TWD 41.9
(-1.53%)
TWD 41.9
(-1.53%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 618.09 Million TWD | 52.14% |
| 2022 | 406.26 Million TWD | 56.46% |
| 2021 | 259.65 Million TWD | -25.88% |
| 2020 | 350.3 Million TWD | -43.47% |
| 2019 | 619.72 Million TWD | -94.0% |
| 2018 | 10.33 Billion TWD | 22.25% |
| 2017 | 8.45 Billion TWD | 35.16% |
| 2016 | 6.25 Billion TWD | 159.17% |
| 2015 | 2.41 Billion TWD | 570.15% |
| 2014 | 359.98 Million TWD | 30.48% |
| 2013 | 275.9 Million TWD | -4.68% |
| 2012 | 289.44 Million TWD | 7.12% |
| 2011 | 270.2 Million TWD | 13.86% |
| 2010 | 237.31 Million TWD | 18.18% |
| 2009 | 200.8 Million TWD | 21.96% |
| 2008 | 164.65 Million TWD | 13.34% |
| 2007 | 145.27 Million TWD | 14.12% |
| 2006 | 127.3 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 191.01 Million TWD | 16.0% |
| 2024 Q1 | 164.67 Million TWD | -9.95% |
| 2023 Q2 | 142.45 Million TWD | 1.34% |
| 2023 Q4 | 182.86 Million TWD | 20.14% |
| 2023 Q3 | 152.2 Million TWD | 6.84% |
| 2023 FY | 618.09 Million TWD | 52.14% |
| 2023 Q1 | 140.57 Million TWD | 7.68% |
| 2022 Q3 | 96.99 Million TWD | -6.41% |
| 2022 Q2 | 103.64 Million TWD | 38.05% |
| 2022 Q4 | 130.54 Million TWD | 34.59% |
| 2022 FY | 406.26 Million TWD | 56.46% |
| 2022 Q1 | 75.07 Million TWD | 16.4% |
| 2021 FY | 259.65 Million TWD | -25.88% |
| 2021 Q3 | 44.06 Million TWD | -31.39% |
| 2021 Q4 | 64.5 Million TWD | 46.39% |
| 2021 Q2 | 64.22 Million TWD | -26.08% |
| 2021 Q1 | 86.87 Million TWD | -6.66% |
| 2020 Q4 | 93.07 Million TWD | 62.21% |
| 2020 Q3 | 57.37 Million TWD | 0.4% |
| 2020 Q2 | 57.15 Million TWD | -59.95% |
| 2020 FY | 350.3 Million TWD | -43.47% |
| 2020 Q1 | 142.69 Million TWD | -12.72% |
| 2019 FY | 619.72 Million TWD | -94.0% |
| 2019 Q2 | 143.33 Million TWD | -9.64% |
| 2019 Q3 | 154.25 Million TWD | 7.62% |
| 2019 Q4 | 163.49 Million TWD | 5.98% |
| 2019 Q1 | 158.63 Million TWD | -87.25% |
| 2018 Q2 | 3.36 Billion TWD | 22.72% |
| 2018 FY | 10.33 Billion TWD | 22.25% |
| 2018 Q4 | 1.24 Billion TWD | -58.38% |
| 2018 Q3 | 2.98 Billion TWD | -11.08% |
| 2018 Q1 | 2.73 Billion TWD | -1.61% |
| 2017 Q4 | 2.78 Billion TWD | 33.83% |
| 2017 FY | 8.45 Billion TWD | 35.16% |
| 2017 Q2 | 1.98 Billion TWD | 23.87% |
| 2017 Q3 | 2.07 Billion TWD | 4.75% |
| 2017 Q1 | 1.6 Billion TWD | -21.32% |
| 2016 Q4 | 2.03 Billion TWD | 54.91% |
| 2016 FY | 6.25 Billion TWD | 159.17% |
| 2016 Q3 | 1.31 Billion TWD | -12.74% |
| 2016 Q2 | 1.5 Billion TWD | 8.17% |
| 2016 Q1 | 1.39 Billion TWD | -3.03% |
| 2015 FY | 2.41 Billion TWD | 570.15% |
| 2015 Q1 | 99.82 Million TWD | 4.8% |
| 2015 Q3 | 758.77 Million TWD | 547.97% |
| 2015 Q4 | 1.43 Billion TWD | 89.35% |
| 2015 Q2 | 117.1 Million TWD | 17.31% |
| 2014 Q3 | 95.89 Million TWD | 10.81% |
| 2014 FY | 359.98 Million TWD | 30.48% |
| 2014 Q4 | 95.25 Million TWD | -0.66% |
| 2014 Q2 | 86.53 Million TWD | 5.15% |
| 2014 Q1 | 82.3 Million TWD | -3.8% |
| 2013 Q3 | 61.45 Million TWD | 5.56% |
| 2013 FY | 275.9 Million TWD | -4.68% |
| 2013 Q1 | 70.68 Million TWD | 0.39% |
| 2013 Q2 | 58.21 Million TWD | -17.64% |
| 2013 Q4 | 85.55 Million TWD | 39.23% |
| 2012 Q4 | 70.4 Million TWD | 6.42% |
| 2012 FY | 289.44 Million TWD | 7.12% |
| 2012 Q1 | 78.2 Million TWD | 15.72% |
| 2012 Q2 | 74.67 Million TWD | -4.51% |
| 2012 Q3 | 66.15 Million TWD | -11.41% |
| 2011 Q3 | 54.37 Million TWD | -4.08% |
| 2011 Q4 | 67.58 Million TWD | 24.29% |
| 2011 FY | 270.2 Million TWD | 13.86% |
| 2011 Q1 | 91.57 Million TWD | 22.95% |
| 2011 Q2 | 56.68 Million TWD | -38.1% |
| 2010 Q1 | 56.1 Million TWD | 0.0% |
| 2010 Q2 | 54.37 Million TWD | -3.08% |
| 2010 Q4 | 74.48 Million TWD | 42.29% |
| 2010 FY | 237.31 Million TWD | 18.18% |
| 2010 Q3 | 52.34 Million TWD | -3.74% |
| 2009 FY | 200.8 Million TWD | 21.96% |
| 2008 FY | 164.65 Million TWD | 13.34% |
| 2007 FY | 145.27 Million TWD | 14.12% |
| 2006 FY | 127.3 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Allied Biotech Corporation | 246.43 Million TWD | -150.81% |
| GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | -115.852% |
| Easywell Biomedicals, Inc. | 170.71 Million TWD | -262.056% |
| TTY Biopharm Company Limited | 3.22 Billion TWD | 80.826% |
| Synmosa Biopharma Corporation | 2.11 Billion TWD | 70.844% |
| Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 71.214% |
| Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | -116.005% |
| Orient Pharma Co., Ltd. | 468.66 Million TWD | -31.883% |
| InnoPharmax Inc. | 17.45 Million TWD | -3440.666% |
| Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -152.662% |
| Excelsior Biopharma Inc. | 306.93 Million TWD | -101.379% |
| DV Biomed Co., Ltd. | 764.27 Million TWD | 19.127% |
| Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | -442.321% |
| Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 44.065% |
| UniPharma Co., Ltd. | 51.01 Million TWD | -1111.569% |
| Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -55.717% |
| Alar Pharmaceuticals Inc. | 465.92 Million TWD | -32.661% |
| Winston Medical Supply Co., Ltd. | 347.59 Million TWD | -77.819% |
| Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -104307.77% |
| Bioray Biotech Co., Ltd | 77.65 Million TWD | -695.99% |
| TSH Biopharm Corporation Limited | 399.89 Million TWD | -54.563% |